Patents by Inventor Bengt Von Mentzer

Bengt Von Mentzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHS OF A HYDROCHLORIDE SALT OF PN6047
    Publication number: 20230174525
    Abstract: The present invention relates to a hydrochloride salt of 4-[(3-carbamoylphenyl)[1-(1,3-thiazol-5-ylmethyl)piperidin-4-ylidene]methyl]-N,N-dimethylbenzamide (PN6047) and crystalline forms thereof, more specifically Form HCl2 and Form HCl3 of PN6047. The invention also relates to pharmaceutical compositions comprising such polymorphs, to a process for the preparation of these polymorphs, and to the use of these polymorphs in the treatment or prevention of conditions that are mediated by agonism of the ?-opioid receptor, and in particular in the treatment or prevention of pain.
    Type: Application
    Filed: July 12, 2021
    Publication date: June 8, 2023
    Inventors: Bengt VON MENTZER, Ingemar STARKE, Hans G. NILSSON
  • Diarylmethylidene piperidine derivatives and their use as delta opoid receptor agnists
    Patent number: 10118921
    Abstract: A compound of formula I, for use in pain therapy and a pharmaceutical composition comprising said compound.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: November 6, 2018
    Assignee: PHARMNOVO AB
    Inventors: Bengt Von Mentzer, Ingemar Starke, Peter Brandt
  • DIARYLMETHYLIDENE PIPERIDINE DERIVATIVES AND THEIR USE AS DELTA OPOID RECEPTOR AGNISTS
    Publication number: 20170327491
    Abstract: A compound of formula I, for use in pain therapy and a pharmaceutical composition comprising said compound.
    Type: Application
    Filed: December 17, 2015
    Publication date: November 16, 2017
    Inventors: Bengt VON MENTZER, Ingemar STARKE, Peter Brandt
  • Molecules
    Publication number: 20070248995
    Abstract: This invention relates to the gene encoding gerbil neurokinin 1 receptor (gNK1r) and to proteins encoded by the gene, as well as to means of regulating their biological activity. In addition the invention relates to the use of the gene and protein to identify therapeutic agents for controlling asthma, pain, depression, anxiety, emesis, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), functional dyspepsia, migraine, urinary incontinence and schizophrenia.
    Type: Application
    Filed: March 16, 2005
    Publication date: October 25, 2007
    Inventors: Tomas Drmota, Susanna Engberg, Bengt Von Mentzer